Previous Close | 14.47 |
Open | 14.47 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 14.47 - 14.47 |
52 Week Range | 14.47 - 20.28 |
Volume | |
Avg. Volume | 482 |
Market Cap | 6.943B |
Beta (5Y Monthly) | 0.18 |
PE Ratio (TTM) | 8.51 |
EPS (TTM) | 1.70 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.53 (3.65%) |
Ex-Dividend Date | Mar 28, 2024 |
1y Target Est | N/A |
Q4 2023 Cue Biopharma Inc Earnings Call
Advancements in Clinical Trials and Strong Cash Position Highlighted
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P. ("OVI FI"), which was established as a corporate venture capital fund in CA, USA in May 2020.